FindTrial
Sign In

Identifying Somatic Mutations in Solid Tumors By Whole Exome Sequencing of Circulating Tumor DNA

Identifying Somatic Mutations in Solid Tumors By Whole Exome Sequencing of Circulating Tumor DNA

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230125001
Enrollment
80
Registered
2023-01-25
Start date
2018-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor, all stages solid, tumor, cancer, circulating tumor DNA, cell-free DNA, whole exome sequencing, variant calling, somatic mutation, blood

Interventions

Screening for somatic mutation ib tumor and circulating tumor DNA
Screening
Somatic mutation

Sponsors

Chulalongkorn University
Lead Sponsor
Chulalongkorn Academic Advancement into Its 2nd Century Project,the grants for development of new faculty Staff, Ratchadaphiseksomphot Fund
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cancer patients that can obtain tissues by surgical procedure or biopsy, and obtain plasma for circulating tumor DNA

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Somatic Mutation At the beginning of the study, specimen collection Whole Exome Sequencing—

Secondary

MeasureTime frame
Germline Mutations At the beginning of the study, specimen collection Whole Exome Sequencing—

Countries

Thailand

Contacts

Public ContactTrairak Pisitkun

Chulalongkorn University

trairak@gmail.com66925370549

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026